TRVI
Trevi Therapeutics Inc
NASDAQ · Pharmaceuticals
$11.46
+0.52 (+4.75%)
Analyst Consensus
Strong Buy
18 analysts
Price Target
Analyst Price Target
+91.4% upside
Low Target
$18.04
Average Target
$21.93
High Target
$33.12
Current Price
$11.46
Current
$11.46
$11.46
Target
$21.93
$21.93
$18.04
$21.93 avg
$33.12